Introduction {#sec1_1}
============

The incidence of skeletal muscle metastases in solid malignancies is reported to be less than 1% of all metastases, despite the fact that skeletal muscle accounts for nearly 50% of the total body weight. Skeletal muscle metastasis as the only site of recurrence of cervical carcinoma is particularly rare. To our knowledge, only 8 cases have been reported in the literature thus far \[[@B1], [@B2]\]. We report the 9th case of a solitary skeletal muscle metastatic lesion from cervical cancer.

Case Report {#sec1_2}
===========

A 51-year-old woman presented to the hospital with swelling in her left arm, which had been increasing in size over the preceding 2 months. She was diagnosed with stage IIIB cervical cancer in April 2012 and was treated with weekly cisplatin and concurrent radiation. She was subsequently lost to follow-up after her treatment until the above presentation 2 years later. On examination, she was noted to have a 7 × 3 cm well-circumscribed mass in the antero-medial aspect of the left forearm, which was minimally tender, nonmobile and not attached to the overlying skin, but changed in size with muscular contraction. She did not have any other masses or palpable lymph nodes. A vaginal examination did not reveal local recurrence. She had a normal complete blood count and biochemical profile. She was HIV negative. A contrast-enhanced MRI of the left arm (Fig. [1](#F1){ref-type="fig"}) revealed a 7.0 × 2.8 × 2.5 cm tumor, deep to the biceps and brachialis, abutting the humeral cortex without apparent bone invasion. A subsequent biopsy revealed large polygonal cells with abundant eosinophilic cytoplasm, typical for squamous cell carcinoma within the deep tissue of the left arm (Fig. [2](#F2){ref-type="fig"}). The cells had a strong and diffuse staining pattern with p16 immunohistochemical staining which was consistent with a human papillomavirus-driven lesion. A staging PET/CT scan showed that the lesion in her arm was the sole site of metastasis and she had no evidence of local recurrence. Since the tumor was seen to be abutting the cortex of the humerus, limb-sparing surgery was not felt to be feasible. Therefore, she was treated with concurrent chemoradiation with weekly cisplatin. She responded extremely well to therapy (Fig. [3](#F3){ref-type="fig"}) and has remained disease-free for 24 months since completing the therapy as evidenced by a PET/CT scan on May 26, 2016.

Discussion {#sec1_3}
==========

The prevalence of skeletal muscle metastasis ranges from 0.03 to 5.6% in autopsy series of patients with cancer \[[@B3], [@B4], [@B5]\]. However, these metastases are rarely detected radiographically as most of these tumors are micrometastatic deposits and patients are often asymptomatic. Surov et al. \[[@B6]\] analyzed 5,172 patients with metastasized cancer and identified 61 patients (with a total of 80 lesions) with skeletal muscle metastases on CT or MRI. Genital tumors were found to be the most common tumors to metastasize to the skeletal muscle (24.6%), followed by gastrointestinal tumors, urologic tumors, and malignant melanomas \[[@B6]\]. Several hypotheses have been postulated to explain the rarity of skeletal muscle metastasis. Contractile movement of the skeletal muscle and constant fluctuations in intramuscular blood pressure may act as mechanical barriers for tumor implantation. The local production of lactic acid, with a relative lack of oxygen can also prevent tumor proliferation. Protease inhibitors located in the skeletal muscle cell basement membrane may play a vital role in preventing invasion of tumor cells as well. Immune-mediated antitumor activity by lymphocytes and natural killer cells within the skeletal muscle are other postulated theories that help reduce the incidence of metastasis \[[@B7]\].

A solitary metastatic lesion from a remote primary cervical cancer is particularly uncommon. The rate of recurrence decreases with an increasing disease-free interval. If a patient has a disease-free interval of more than 5 years, the recurrence is approximately 4%. The incidence of recurrence increases with the stage of initial diagnosis, and is 8.5% overall for stage III disease \[[@B8]\].

Differentiating skeletal muscle metastasis and soft tissue sarcoma radiographically can be difficult. Though needle biopsy is needed for a definite diagnosis, radiological imaging can provide valuable information. Compared with MRI, a plain radiogram and CT are of little value with regard to the characterization of the mass. MRI with intravenous gadolinium enhancement can be helpful when planning the biopsy of these lesions, as it is useful to evaluate the vascularity of the tumor. Extensive peritumoral enhancement associated with central necrosis is one of the characteristic features of the skeletal muscle metastasis. Other than the pathological features that suggest squamous cell malignancy, positive staining for the p16 immunohistochemical stain is pathognomonic for a human papillomavirus-driven lesion \[[@B9], [@B10]\].

The general clinical outcome of patients with isolated skeletal metastasis is poor as suggested by the previous case reports. This is most likely due to the presence of more diffuse, occult metastasis. A palliative approach is usually taken in these patients. However, patients with isolated distant metastatic disease may be amenable to local treatment. Treatment could include surgical resection with or without concurrent radiation, or radiation with or without concurrent chemotherapy. Our patient had a single skeletal lesion in her left arm with no evidence of any other metastatic lesions. There have been no established guidelines for the management of these situations due to the dearth of such occurrences.

This experience emphasizes the importance of dedicated long-term follow-up in cervical cancer survivors. Remote recurrence of this disease, though uncommon, does occur. With the robust expansion of targeted therapies, longer periods of overall survival are feasible \[[@B11]\]. Patients with isolated recurrences may even be cured with aggressive therapy.

Statement of Ethics {#sec1_4}
===================

The authors have no ethical conflicts to disclose.

Disclosure Statement {#sec1_5}
====================

The authors have no conflicts of interest to declare.

![Pretreatment MRI (December 2014). Contrast-enhanced T1-weighted images with sagittal and coronal section.](cro-0010-0694-g01){#F1}

![Posttreatment MRI (September 2015). Coronal and sagittal section.](cro-0010-0694-g02){#F2}

![Nests of malignant squamous cells within a background of mostly fibrous tissue with atrophic muscle and chronic inflammation (right panel). The malignant squamous cells demonstrate strong and diffuse positivity for p16 immunohistochemical stain (left panel).](cro-0010-0694-g03){#F3}
